These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 10383131)
1. Human prostate cancer expresses the low affinity insulin-like growth factor binding protein IGFBP-rP1. Degeorges A; Wang F; Frierson HF; Seth A; Chung LW; Sikes RA Cancer Res; 1999 Jun; 59(12):2787-90. PubMed ID: 10383131 [TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1/mac 25) is reduced in human prostate cancer and is inversely related to tumor volume and proliferation index in Lucap 23.12 xenografts. Tennant MK; Vessella RL; Sprenger CC; Sikes RA; Hwa V; Baker LD; Plymate SR Prostate; 2003 Jul; 56(2):115-22. PubMed ID: 12746836 [TBL] [Abstract][Full Text] [Related]
3. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis. Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184 [TBL] [Abstract][Full Text] [Related]
4. Restoration of insulin-like growth factor binding protein-related protein 1 has a tumor-suppressive activity through induction of apoptosis in human prostate cancer. Mutaguchi K; Yasumoto H; Mita K; Matsubara A; Shiina H; Igawa M; Dahiya R; Usui T Cancer Res; 2003 Nov; 63(22):7717-23. PubMed ID: 14633696 [TBL] [Abstract][Full Text] [Related]
5. Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Sprenger CC; Damon SE; Hwa V; Rosenfeld RG; Plymate SR Cancer Res; 1999 May; 59(10):2370-5. PubMed ID: 10344746 [TBL] [Abstract][Full Text] [Related]
6. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells. Stewart LV; Weigel NL Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors. Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696 [TBL] [Abstract][Full Text] [Related]
8. Prostate carcinoma cells that have resided in bone have an upregulated IGF-I axis. Rubin J; Chung LW; Fan X; Zhu L; Murphy TC; Nanes MS; Rosen CJ Prostate; 2004 Jan; 58(1):41-9. PubMed ID: 14673951 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-3 (IGFBP-3) in the prostate and in prostate cancer: local production, distribution and secretion pattern indicate a role in stromal-epithelial interaction. Massoner P; Haag P; Seifarth C; Jurgeit A; Rogatsch H; Doppler W; Bartsch G; Klocker H Prostate; 2008 Aug; 68(11):1165-78. PubMed ID: 18459102 [TBL] [Abstract][Full Text] [Related]
10. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635 [TBL] [Abstract][Full Text] [Related]
12. Distribution of IGFBP-rP1 in normal human tissues. Degeorges A; Wang F; Frierson HF; Seth A; Sikes RA J Histochem Cytochem; 2000 Jun; 48(6):747-54. PubMed ID: 10820148 [TBL] [Abstract][Full Text] [Related]
13. Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. Figueroa JA; Jackson JG; McGuire WL; Krywicki RF; Yee D J Cell Biochem; 1993 Jun; 52(2):196-205. PubMed ID: 7690042 [TBL] [Abstract][Full Text] [Related]
14. Identification of membrane-bound serine proteinase matriptase as processing enzyme of insulin-like growth factor binding protein-related protein-1 (IGFBP-rP1/angiomodulin/mac25). Ahmed S; Jin X; Yagi M; Yasuda C; Sato Y; Higashi S; Lin CY; Dickson RB; Miyazaki K FEBS J; 2006 Feb; 273(3):615-27. PubMed ID: 16420484 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I. Kawada M; Inoue H; Arakawa M; Ikeda D Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013 [TBL] [Abstract][Full Text] [Related]
16. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). López-Bermejo A; Khosravi J; Fernández-Real JM; Hwa V; Pratt KL; Casamitjana R; Garcia-Gil MM; Rosenfeld RG; Ricart W Diabetes; 2006 Aug; 55(8):2333-9. PubMed ID: 16873698 [TBL] [Abstract][Full Text] [Related]
17. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3. Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112 [TBL] [Abstract][Full Text] [Related]
18. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors. Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944 [TBL] [Abstract][Full Text] [Related]
19. Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rPs) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. López-Bermejo A; Buckway CK; Devi GR; Hwa V; Plymate SR; Oh Y; Rosenfeld RG Endocrinology; 2000 Nov; 141(11):4072-80. PubMed ID: 11089538 [TBL] [Abstract][Full Text] [Related]
20. IGF binding protein-3 secreted by the prostate adenocarcinoma cells (PC-3): differential effect on PC-3 and normal prostate cell growth. Kaicer E; Blat C; Imbenotte J; Troalen F; Cussenot O; Calvo F; Harel L Growth Regul; 1993 Sep; 3(3):180-9. PubMed ID: 7693099 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]